Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:08:18 EDT Thu 22 Oct 2026
Enter Symbol
or Name
USA
CA



Q:NEO - NEOGENOMICS INC - https://www.neogenomics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NEO - Q0.315.80·16.480.116.39-0.65-3.82,463.339,66113,59716.89  17.1747  16.1320.15  7.06516:51:46Oct 1515 min RT 2¢

Recent Trades - Last 10 of 13597
Time ETExPriceChangeVolume
16:51:46Q16.468-0.5721
16:39:30Q16.00-1.0440
16:37:00Q16.39-0.65890
16:25:04Q16.39-0.651
16:25:04Q16.39-0.651
16:04:01Q16.39-0.651
16:04:01Q16.39-0.651
16:00:57Q16.39-0.65106
16:00:54Q16.39-0.653,025
16:00:27Q16.39-0.6514

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-10-15 07:05U:NEONews ReleaseNeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology
2026-10-14 07:05U:NEONews ReleaseNeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026
2026-10-05 16:05U:NEONews ReleaseNeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
2026-09-01 07:05U:NEONews ReleaseNeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
2026-08-26 16:17U:NEONews ReleaseNeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring
2026-07-28 16:05U:NEONews ReleaseNeoGenomics Reports Second Quarter 2026 Results
2026-07-20 17:23U:NEONews ReleaseNeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
2026-07-09 07:05U:NEONews ReleaseNeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
2026-07-07 07:05U:NEONews ReleaseNeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
2026-06-25 07:05U:NEONews ReleaseNeoGenomics Appoints Carolyn Starrett to its Board of Directors
2026-06-17 06:00U:NEONews ReleaseNeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
2026-06-15 17:24U:NEONews ReleaseNeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes
2026-05-26 07:05U:NEONews ReleaseNeoGenomics to Present New Research at ASCO Annual Meeting 2026
2026-05-15 09:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2026-04-28 16:05U:NEONews ReleaseNeoGenomics Reports First Quarter 2026 Results
2026-04-23 07:05U:NEONews ReleaseNeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
2026-04-13 07:05U:NEONews ReleaseNeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
2026-04-07 07:05U:NEONews ReleaseNeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
2026-03-16 07:05U:NEONews ReleaseNeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
2026-02-25 07:05U:NEONews ReleaseNeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types